Miglustat is a drug developed by Actelion and is used primarily to treat Type 1 Gaucher disease (GD1). It is marketed under the trade name Zavesca . Miglustat is an N-alkylated imino sugar, a synthetic analogue of D-glucose and a white to off-white crystalline solid that has a bitter taste. more

Miglustat is a drug developed by Actelion and is used primarily to treat Type 1 Gaucher disease (GD1). It is marketed under the trade name Zavesca . Miglustat is an N-alkylated imino sugar, a synthetic analogue of D-glucose and a white to off-white crystalline solid that has a bitter taste. The chemical name for miglustat is 1,5-(butylimino)-1,5-dideoxy-D-glucitol with the chemical formula C10H21NO4 and a molecular weight of 219.28. With its unique physico-chemical properties miglustat exhibits a large volume of distribution and has the capacity to access deep organs such as the brain, bone and lung. less